Clinical Trials Browser

Unknown × Hematologic Diseases × Lymphoid × Clear all

Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, Hemorrhagic Disorders, Immune System Diseases, Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Neoplasms by Histologic Type, Paraproteinemias, Vascular Diseases, Neoplasm, Residual, Hemostatic Disorders, Neoplasms, Plasma Cell

NCT03556748 2018-06-14

WB-EMS and Nutrition in Patients With Hematological Malignancies

Phase NA Unknown

40 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Cachexia, Hematologic Diseases, Leukemia, Lymphoma, Motor Activity, Neoplasms, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT01435720 2014-09-11

Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)

Phase 1/2 Unknown

15 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Blood Protein Disorders, Hematologic Diseases, Leukemia, Plasma Cell, Multiple Myeloma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell

Clinical Trials

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

WB-EMS and Nutrition in Patients With Hematological Malignancies

Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL)